AML (Acute Myeloid Leukemia) Dual Inhibitor of Mutant Isocitrate Dehydrogenase (IDH) 1 and 2 in R/R Myeloid HM Patients Sep 04, 2023
AML (Acute Myeloid Leukemia),Leukemia First-In-Human Study of NEXI-001 for Relapsed AML Patients Aug 23, 2023
AML (Acute Myeloid Leukemia) Decitabine, Venetoclax, and Ponatinib Combination in CML and Ph+ AML Patients: Accelerated Phase to Blast Phase. Aug 21, 2023
AML (Acute Myeloid Leukemia),Leukemia Examining the Efficacy of Gilteritinib (ASP2215) in Treating Acute Myeloid Leukemia with FLT3 Gene Mutation May 03, 2023
AML (Acute Myeloid Leukemia),Leukemia Molecular Profiling of IDH1-Mutated ND-AML Patients in AGILE Study Mar 23, 2023
AML (Acute Myeloid Leukemia),Leukemia AML Long-term Outcomes After Allo-SCT With Decitabine and Venetoclax Mar 23, 2023
AML (Acute Myeloid Leukemia),Leukemia Phase 3 Viale-a Study: Ven Plus Aza for AML Treatment Mar 23, 2023
AML (Acute Myeloid Leukemia),Leukemia ADMIRAL trial: Gilteritinib vs. Chemotherapy for FLT3-Mutated AML Transplant Outcomes Mar 23, 2023